About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Retrospective Observational Study DIANA Study | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT01976793

Retrospective Observational Study DIANA Study

This Non-Interventional Study (NIS) is intended to evaluate the duration of treatment with an initial antidepressant taken as monotherapy in patients in whom treatment was changed because of suboptima...

Lead sponsor: AstraZeneca•8 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

AstraZeneca

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1\. Female or male aged between 18 and 65 years Inpatients and outpatients diagnosed with an episode of major depression relating to RDD (ICD-10, Version 2010) during the period from January 1, 2012 till September 30, 2013 3. Initially treated with antidepressant monotherapy, using a flexible dosage regimen if required, for at least 2 weeks 4. Initial treatment changed because of a suboptimal response at physician's discretion, which is clearly documented in the patient's medical chart.

Exclusion Criteria

•Patients currently participating in any other clinical or non-interventional trial, or have completed their participation with the last 30 days.
•2\. Patients with current psychiatric or general medical conditions which require concomitant use of lithium, thyroid hormones, or atypical antipsychotics 3. Patients with unstable general medical condition. 4. Patients who were pregnant or were suspected to be pregnant during the period when a patient had received treatment for MDE (Major Depressive Episode).

Related studies

LHC-CIDI-5 in Hong Kong

NCT06804525 · Major Depressive Episode (MDE), Major Depressive Disorder (MDD), and more

University of Iowa Interventional Psychiatry Service Patient Registry

NCT04480918 · Treatment Resistant Depression, Major Depressive Episode, and more

Presynaptic Imaging in Major Depressive Episodes After COVID-19

NCT06086366 · Long COVID, Major Depressive Disorder, and more

Validation of a Composite Medical Device Using a Blood Biomarker-based Algorithm and MDQ for the Diagnosis of Bipolar Disorder

NCT07031817 · Bipolar Disorder (BD), Major Depressive Episode (MDE), and more

RECRUITINGPhase 3

Early Effects of Ketamine vs Placebo With Venlafaxine in Severe Depression Patients

NCT06508710 · Major Depressive Episode

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 13, 2014Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment450

Start dateDec 2013

Last updatedNov 13, 2014

Condition

Major Depressive Episode

Locations shown

Research Site

Ivanovo

Research Site

Kazan'

Research Site

Moscow

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 13, 2014Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions